Corporate News 24-Nov-23
Gland Pharma's Pashamylaram unit clears USFDA inspection
Gland Pharma has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection of its Pashamylaram facility in Hyderabad.
Previous News
Gland Pharma appoints Srinivas Sadu as Executive Chairman and CEO
( Corporate News - 08-Jun-24 12:56 )
Indices hit record high; Sensex breaches 75K; broader mkt underperforms
( Market Commentary - Mid-Session 23-May-24 13:32 )
Gland Pharma Ltd up for third straight session
( Hot Pursuit - 31-Jul-23 13:05 )
Volumes soar at Axis Bank Ltd counter
( Hot Pursuit - 09-Apr-24 11:00 )
Gland Pharma appoints Srinivas Sadu as executive chairman & CEO
( Hot Pursuit - 08-Jun-24 13:23 )
Volumes spurt at Symphony Ltd counter
( Hot Pursuit - 10-Jul-23 11:00 )
Gland Pharma
( Results - Analysis 08-Aug-23 11:02 )
Volumes spurt at Gland Pharma Ltd counter
( Hot Pursuit - 07-Nov-23 11:00 )
Gland Pharma Ltd up for third straight session
( Hot Pursuit - 17-Jul-23 13:05 )
Gland Pharma to conduct AGM
( Corporate News - 23-May-22 14:15 )
Gland Pharma to conduct board meeting
( Corporate News - 05-Jul-22 10:28 )
Other Stories
Share India Securities allots 16.92 lakh equity shares on conversion of warrants
06-Jul-24 13:11
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Back
Top
